Skip to main navigation
Skip to search
Skip to main content
Arizona Board of Regents Home
Home
Profiles
Departments and Centers
Scholarly Works
Grants
Activities
Equipment
Datasets
Press/Media
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Bo Sun
University of Arizona
,
Pharmacology and Toxicology
h-index
893
Citations
14
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2012
2023
Research activity per year
Overview
Fingerprint
Network
Scholarly Works
(21)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Bo Sun is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Neoplasm
87%
Paclitaxel
72%
Malignant Neoplasm
70%
High Density Lipoprotein
61%
Lipoprotein
60%
Cell Culture
53%
Drug Release
53%
Immunotherapy
51%
Doxorubicin
46%
Intraperitoneal Chemotherapy
30%
Donepezil
26%
Rocuronium
26%
Combination Therapy
26%
Cell Viability
26%
Alzheimer's Disease
26%
Hepatotoxicity
26%
Nanomaterial
26%
Ovary Cancer
26%
Immunologic Adjuvant
23%
Adjuvant
19%
Colon Cancer
17%
Indocyanine Green
15%
Mouse
13%
Carbomer
13%
Autacoid
13%
Tumor Antigen
13%
Protein Kinases
12%
Non Melanoma Skin Cancer
12%
Cytotoxicity
12%
Melanoma
11%
Benzeneboronic Acid
10%
Reverse Phase High Performance Liquid Chromatography
8%
Cancer Growth
8%
Viability Assay
8%
Fourier Transform Infrared Spectroscopy
8%
Differential Scanning Calorimetry
8%
Octadecylamine
8%
Skin Cancer
8%
Squamous Cell Carcinoma
8%
Lymphokine
8%
Raman Microscopy
8%
Scanning Electron Microscopy
8%
Normal Human
8%
Drug Formulation
7%
Acetylcholinesterase
7%
Apolipoprotein A
7%
Skin Carcinoma
7%
Median Survival Time
6%
Drug Delivery System
6%
Keyphrases
Cancer Immunotherapy
53%
Nanoparticle Delivery
26%
Release Kinetics Study
26%
Flexible Modulation
26%
Delivery Platform
26%
Stimuli-responsive Gel
26%
Discoidal Lipoprotein
26%
TOPK Inhibitor
26%
Radiation Oncology
26%
Adjuvant Delivery
26%
Relay Drug Delivery
26%
Intracellular Drug Release
26%
Chemo-phototherapy
26%
Nanopatch
26%
In Vitro Permeation
26%
Circulating Tumor Cells
26%
Nanotechnology
26%
Carrier-free Delivery
26%
In Situ Crosslinkable
26%
Paclitaxel Nanocrystals
26%
Clinical Oncology
15%
Receptor Targets
13%
Vaccine Formulation
13%
Tumor Antigen
13%
Clinical Translation
13%
Physicochemical Evaluation
13%
Skin Cell Line
13%
Strat-M®
13%
Targeted Delivery
13%
Pattern Recognition Receptors
13%
Infectious Diseases
13%
Site-specific Targeting
13%
Personal Health
13%
Bioinformatics Methods
13%
Combined Delivery
13%
Tumor Neoantigens
13%
Public Health
13%
Subunit Vaccine
13%
Nanoparticle Gel
13%
Cancer Monitoring
8%
Prognostic Biomarker
8%
Molecular Profile
8%
Imaging Agents
8%
Dynamic Molecular
8%
Invasive Procedures
8%
Tumor
8%
Less Invasive
8%
Nanotherapeutics
8%
Diagnostic Tool
8%
Therapeutic Agents
8%
Medicine and Dentistry
Cancer Immunotherapy
42%
Nanomedicine
33%
Tumor Microenvironment
33%
Circulating Tumor Cell
26%
Peritoneum Adhesion
26%
Immunosuppressive Drug
26%
Radiation Oncology
26%
Nanoparticle
26%
Neoplasm
24%
Immunocompetent Cell
22%
Tissue Adhesion
17%
Nanomaterial
17%
Clinical Oncology
15%
Clinical Study
8%
Tumor Marker
8%
Diagnosis
8%
Imaging Agent
8%
Cancer Diagnosis
8%
Side Effect
8%
Cancer Epidemiology
8%
Anatomical Barrier
8%
Digestive System Surgery
8%
Biopsy
8%
Advanced Cancer
6%
Non Small Cell Lung Cancer
6%
Nodular Melanoma
6%
Malignant Neoplasm
6%
T Cell
6%
Nucleic Acid
6%
Stroma
5%
Innate Immunity
5%
Cytokine
5%
Skin Cell Line
5%
Scanning Electron Microscopy-Energy Dispersive X-Ray
5%
Adaptive Immunity
5%
Immunotherapy
5%
